STOCK TITAN

Illumina (NASDAQ: ILMN) grants stock and performance units to senior executive

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Illumina, Inc. reported that Chief of Global Operations Kevin Carl Pegels acquired new equity awards on March 5, 2026. He received 6,317 shares of common stock as restricted stock units at a reference price of $128.24 per share, vesting 25% each on February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, contingent on continued service.

He was also granted two tranches of performance stock units, each for 7,369 performance shares. One tranche vests on December 31, 2028 based on three-year average consolidated non-GAAP EPS growth for fiscal years 2026–2028, and the other on relative total shareholder return for the fiscal year ending December 31, 2028. In both cases, payout can range from 0% to 250% of the target amount, depending on performance and continued service. Following the common stock grant, he directly owned 29,038 shares of Illumina common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pegels Kevin Carl

(Last) (First) (Middle)
5200 ILLUMINA WAY

(Street)
SAN DIEGO CA 92122

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ILLUMINA, INC. [ ILMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief of Global Operations
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 A 6,317(1) A $128.24 29,038 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Shares (2) 03/05/2026 A 7,369 (2) 12/31/2028 Common Stock 7,369 $128.24 7,369 D
Performance Shares (3) 03/05/2026 A 7,369 (3) 12/31/2028 Common Stock 7,369 $128.24 7,369 D
Explanation of Responses:
1. Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.
2. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.
3. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.
By: Robert Maynes for Kevin Pegels 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Illumina (ILMN) report in Kevin Carl Pegels’ latest Form 4?

Illumina reported that Kevin Carl Pegels received new equity awards on March 5, 2026. These included restricted stock units in common stock and performance stock units tied to earnings growth and total shareholder return, all contingent on future vesting conditions and continued service.

How many Illumina (ILMN) restricted stock units did Kevin Carl Pegels receive?

Kevin Carl Pegels received 6,317 restricted stock units in Illumina common stock at a reference price of $128.24 per share. These units vest in four equal 25% installments on February 15 of 2027, 2028, 2029, and 2030, subject to his continued service.

What performance conditions apply to Kevin Carl Pegels’ Illumina (ILMN) EPS-based performance stock units?

One 7,369-share tranche of performance stock units depends on Illumina’s three-year average consolidated non-GAAP EPS growth for fiscal years 2026–2028. Vesting occurs on December 31, 2028, with shares earned between 0% and 250% of target based on predefined performance objectives and continued service.

How are Kevin Carl Pegels’ Illumina (ILMN) TSR-based performance stock units structured?

A separate 7,369-share tranche of performance stock units is tied to Illumina’s relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued can range from 0% to 250% of target, depending on performance versus predefined goals and continued service.

What is Kevin Carl Pegels’ Illumina (ILMN) common stock ownership after these grants?

After the March 5, 2026 grant of 6,317 restricted stock units, Kevin Carl Pegels directly owned 29,038 shares of Illumina common stock. This figure reflects his direct holdings reported in the Form 4 and excludes unvested or contingent performance stock units.

When do Kevin Carl Pegels’ Illumina (ILMN) restricted stock units fully vest?

The 6,317 restricted stock units are scheduled to vest in four equal installments. Vesting dates are February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, and each tranche requires Kevin Carl Pegels to maintain service through the applicable date.
Illumina Inc

NASDAQ:ILMN

View ILMN Stock Overview

ILMN Rankings

ILMN Latest News

ILMN Latest SEC Filings

ILMN Stock Data

18.71B
152.21M
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SAN DIEGO